T he emergence of a recently identified toxic dinoflagellate, Pfiesteria piscicida, creates new human health risks in the laboratory and natural environment. This potential for human illness was first recognized when marine scientists themselves became ill while studying the effects of this microorganism on fish health (Glasgow et al. 1995, Schmechel and Koltai 2000) . One investigator's symptoms were so severe that hospitalization was necessary. Similar illnesses in attenuated form were anecdotally reported in persons with extended contact with North Carolina estuary waters where Pfiesteria-associated toxicity was present (Glasgow et al. 1995) . When commercial and recreational fishermen in Maryland came in repeated contact with fish kills and estuary waters containing at least 200 to 350 cells per ml of the organism, reports of illness increased and cognitive disturbances were objectively documented .
Our group at the University of Maryland became interested in these issues when commercial and recreational fisherman in Maryland-after repeated contact with fish kills and estuary water where the organism was known to be present-reported illness, including subjective "memory problems." They reported episodes of confusion, a dramatic increase in distractibility, and forgetfulness, which interfered with their work and other daily activities. Through a series of studies, we found objective evidence for cognitive disturbances in persons with high levels of exposure to the organism. Our findings were consistent with the complaints of the fishermen. This was the first demonstration that disturbances in thinking or cognition could result from environmental contact with P. piscicida . Although the fishermen were reassured that there was a potential explanation for their new symptoms, the findings stimulated concern among members of our medical team. Subsequently, the diverse researchers of our medical team embarked on a new series of basic science and clinical studies to unravel the mystery of this newly emerging environmental toxin and its human health effects.
However, as one would expect with a newly identified clinical syndrome, knowledge of the human health effects of exposure to a Pfiesteria-related toxin remains in its infancy. Available data suggest that Pfiesteria, when appropriately stimulated by the presence of fish or fish products, releases a toxin into its immediate environment (Burkholder et al. 1992 , Glasgow et al. 1995 , Noga et al. 1993 . The specific triggers from toxin production are not known, nor has the toxin itself been fully characterized or purified. People appear HEALTH to be exposed to the toxin through one of the two routes: inhalation of aerosolized vapors or dermal contact with the toxic water. The neural mechanisms underlying the cognitive alterations remain unknown. Preliminary studies of rats suggest that the N-methyl-p-aspartate (NMDA) neurotransmitter may be the target for P. piscicida (El Nabawi et al. 2000) . In summarizing their initial findings, the authors raise the possibility that the putative toxin has an inhibitory effect on NMDA-receptor binding in the brain, the effect of which may be responsible for memory problems in the exposed person (El Nabawi et al. 2000) . The precise intensity and duration of exposure necessary for human illness is minimally known. Nevertheless, in persons with environmental exposure there appears to be a dose-response relationship, as the most significant neurocognitive alterations were documented in persons with daily, intense exposure to Pfiesteria-laden water and active fish kills over several months. It is noteworthy that eating fish from the affected waters does not appear to produce a Pfiesteria-related symptom complex (Golub et al. 1998) .
Extended studies are under way to specifically define the symptom complex associated with Pfiesteria-related illness, determine the recovery course, and identify human risk factors for symptom development. Meanwhile, early findings indicate that some aspects of human health appear to be affected more than others, that there may be a relationship among the affected human systems, and that the cognitive alterations in humans may parallel those identified in animal models. This review is based on the current knowledge of the medical, neurologic, and cognitive sequelae of exposure to P. piscicida. The recovery course and effects of repeated exposure are also discussed to the extent that preliminary data are available. The body of knowledge we review, albeit inconclusive, has potentially important implications for the health and safety of persons whose occupations or recreational activity put them in contact with "high-risk" estuarine waters. We anticipate this knowledge will be used to provide direction for the medical assessment of exposed, ill individuals and to stimulate further systematic, hypothesis-driven research.
Effects on human health
The general medical complaints of individuals exposed in the laboratory and environmental settings are similar. These include acute respiratory and eye irritation, gastroenteritis (stomach cramps, nausea, and vomiting), fatigue, and headaches (Glasgow et al. 1995 , Shoemaker 1998 , Morris 1999 , Oldach et al. 1999 ). The symptoms persist up to 2 weeks, depending upon the intensity and duration of contact with Pfiesteria-affected water. As a group, individuals with extended, repeated contact with water having high concentrations of Pfiesteria-like organisms (350-400 cells per ml) also had dermatologic and cognitive symptoms (described below). Persons with a more limited environmental exposure, both in intensity and duration, were more likely to have a transient flu-like illness with gastrointestinal symptoms and headache. Although some persons complained of transient changes in mental status (confusion, disorientation), there were no detectable cognitive disturbances 2 or 3 weeks after exposure (Oldach et al. 1999) . In summarizing the medical findings associated with several different types of environmental exposures using case-control paradigms, Oldach and colleagues (1999) hypothesize that graded responses occur.
The variability in environmental exposure and acute medical symptomatology, combined with the relatively rapid recovery of medical symptoms for most mildly exposed individuals, partly explains the inconclusive findings of the North Carolina "crabbers study" in 1996 (Morris 1996) . In this study, the majority of participants were retrospectively evaluated through telephone interviews several weeks after minimal exposures to three different fish kill events. When standardized cognitive evaluations were completed, only three persons were examined, and the exams took place 2 months after exposure. Despite its methodological limitations, this early study provided a window on the complexity inherent in investigating the human health effects of exposure to toxic Pfiesteria or a related organism.
Neurologic and neuroimaging studies
Clinical neurologic exam. Clinical neurologic symptoms associated with laboratory exposure include alterations in mental status, cognition, mood and personality, numbness and tingling in upper extremities, pendular reflexes, mild dyskinesia, and ataxia. Electromyography in one case showed evidence of possibly axonopathy. In this same individual, lumbar puncture yielded spinal fluid that contained elevated protein and immunoglobulins but was otherwise normal.
Cerebral MRI studies. To date, MRI (magnetic resonance imaging) data have not been systematically collected on all exposed, symptomatic persons. Several persons with severe alterations in mental status or cognition after environmental exposure underwent MRI studies as part of their clinical evaluations. These were completed to determine whether the toxic exposure disrupted the structural integrity of their brains. In all cases of environmental exposure in Maryland, where cerebral MRI data were obtained, results were interpreted as normal. It is noteworthy, however, that the MRI findings for one of the severely affected laboratory workers (Glasgow et al. 1995 ) indicated a mild abnormality in the left hippocampus. The clinical significance of this abnormality remains to be determined. It is possible that repeated laboratory exposure over several years contributes to structural cerebral abnormality. Alternatively, the abnormality could have predated the exposure, potentially leaving the exposed individuals more vulnerable to the effects of the Pfiesteria-associated toxin.
FDG-PET studies. Because neural functions are often disrupted before structural changes are detectable, procedures were introduced into several studies to determine the presence of absence of nonfunctioning neural tissue. FDG-PET (fluorodeoxyglucose combined with positron emission tomography) studies were completed on several persons who were exposed to the toxin to assess neuropsychological activity. Findings were normal for the laboratory worker (Glasgow et al. 1995) who underwent this procedure. However, similar clinical studies of a group (n = 8) of environmentally exposed, symptomatic persons suggested considerable variability among the participants. Several different patterns of uptake of FDG were noted in these clinical studies, ranging from normal (in the mildly exposed group) to abnormal (Civelek et al. 1998) . To date no specific pattern of functional abnormality has been established. Given the complexity inherent in performing and interpreting FDG-PET studies, the wide range of normal variability and sensitivity of this functional measure to individual cognitive and emotional states, extended case-control studies are under way to determine the meaningfulness of the initial clinical findings.
Sensory studies. Several persons with environmental exposures reported decreased olfaction, which was confirmed on clinical examination. However, further studies are needed to determine whether the disturbances in smell represent a primary central nervous system-based sensory disturbance or coexisting upper respiratory system inflammation. Numbness and tingling was reported by many watermen when they had direct contract with Pfiesteriainfected water. In all likelihood, this represents skin irritation and not brain-based somatosensory disturbance. Unlike persons with ciguatera poisoning, no hot-cold temperature reversals were reported.
Visual acuity, color discrimination, visual organization, visually guided movements, and constructional abilities (e.g., block constrictions, copying complex geometric shapes) do not appear to be affected by environmental exposure. However, the possibility of disturbances in visual contrast sensitivity (VCS) was raised in an environmentally exposed cohort in North Carolina 2 to 3 months after exposure (Hudnell 1998) .VCS refers to the smallest luminance difference between adjacent areas (contrast) necessary for detection across sizes (Hudnell et al. 1996) . People with disturbances in VCS would have compromised visual-pattern detection skills. Although these findings remain preliminary, they raise the possibility of a visual system disruption that may be persistent.
Dermatological findings. Skin complaints, including
episodic burning upon water contact, were common in environmentally exposed persons in Maryland in 1997. Relief from the burning sensation was found by rinsing hands with bottled water, and, in some cases, bleach. Other common skin complaints included itching, red bumps or sores, and scaling flat regions. Histologic findings from the Maryland Pocomoke River study (Gratten et al. 1998, Lowitt and Kauffman 1998) indicated that a subset of persons had otherwise unexplained erythematous, edematous papules on the trunk or extremities suggestive of an inflammatory, toxic, or allergic process. Skin lesions have been reported in fishermen exposed to toxic Pfiesteria activity in North Carolina (Glasgow et al. 1995) . Similarly, a marine scientist with repeated laboratory exposures also developed skin infections and open sores over his chest and arms, which were thought to be associated with exposure (Glasgow et al. 1995) . Taking into consideration the cognitive and other medical symptoms reported to date, as well as available exposure data, it appears as though otherwise unexplained skin lesions suggestive of a toxic or allergic process occur in persons whose exposures were of high intensity and duration (Lowitt and Kauffman 1998) . Further studies are under way to test this hypothesis.
Neuropsychological findings.
A diversity of neuropsychological complaints have been reported following both environmental and laboratory exposures. In the cognitive domain, these include newly acquired disturbances in the ability to focus and sustain attention, trouble remembering tasks or conversations, difficulty performing simultaneous tasks, and an increase in distractibility (Glasgow et al. 1995 . Acute episodes of confusion and the new onset of reading problems and disturbed personal, spatial, and temporal orientation were also reported in persons with the highest levels of exposure in the laboratory and environment (Glasgow et al. 1995) . When a series of environmentally exposed persons were systematically studied in Maryland with a screening battery of cognitive and behavioral measures, the most frequently identified cognitive deficit was in the acquisition of new knowledge or learning . This disturbance in the ability to learn new information occurred within the context of coexisting disturbances in selective or divided attention. Hence, there is the possibility that the observed and reported problems in new learning and memory are actually secondary to difficulty in focusing and sustaining attention in the presence of distracting or competing information. The extent of the problem in new learning was proportionate to the amount of time the participants spent in contact with fish kills. The highly exposed persons (20-40 hours per week of toxic water contact during active fish kill events) had a significantly greater degree of disturbance than the mildly or moderately exposed groups.
Similar disturbances in new learning were found in laboratory rats. Rats with an intraperitoneal injection of cells and water from active toxin-producing Pfiesteria cultures had significantly greater learning difficulties in an eight-arm radial maze task compared with control rats (Levin et al. 1997) . In a follow-up study (Levin et al. 1999) , the negative impact of distracting stimuli was observed. The eight-arm radial maze learning deficit in Pfiesteria-exposed rats was replicated when rats were tested in the standard room, but it was was not observed when the rats were tested in a sound-attenuated chamber (Levin et al. 1999) . Hence, the convergence of human and animal data suggests that an increased susceptibility to distraction may be associated with Pfiesteria-induced learning and memory deficits.
The potential impact of environmental exposure, however, cannot be completely explained by disturbances in divided attention or new learning. Published group data analyses did not reflect the symptom variability among exposed participants in the Pocomoke, Maryland, study. Analysis of individual cases suggested considerable diversity in the cognitive sequelae of exposure, particularly in persons with high levels of exposure. Three participants in the high-exposure group were functionally amnestic with severe levels of impairment on measures of anterograde memory (new learning, free recall, and recognition memory), concentration, and psychomotor speed and dexterity. Regardless of exposure level, language, visual spatial, and constructional abilities remained unaffected in the Maryland study.
The aforementioned cognitive findings could not be explained by alterations in mood, anxiety, factitious memory disturbance, malingering, or mass hysteria . However, in persons with repeated high levels of exposure, the possibility of alterations in mood, affect, or personality after exposure cannot be precluded. Glasgow and colleagues (1995) reported that a premorbidly mild-mannered individual had the new onset of irritability and even some rate attacks after repeated, intense laboratory exposures. Such personality findings are not inconsistent with the potential effects of neurotoxic or neurologic insult and therefore need to be considered as potential sequelae of exposure.
Recovery and repeated exposure. Extent data (Glasgow et al. 1995 suggest that the acute neuropsychological sequelae of laboratory and environmental exposures spontaneously resolve over time. In the case of environmental exposure, the rate of recovery is proportionate to the initial degree of exposure and neuropsychological insult (see Figure 1 ). Most exposed persons were performing within the normal range, compared with national norms and their own controls, by 3 months postexposure. Persons in the highly exposed group, with the most severe acute memory problems, returned to the normal range of performance 6 months postexposure. In the absence of baseline cognitive data and comprehensive neuropsychological assessment, we cannot definitively conclude that recovery was complete; however, rudimentary cognitive functions were significantly improved 6 months postexposure.
An additional and important concern is the possible effect of reexposure. It is well established that individuals who have an episode of ciguatara poisoning may have symptom recurrence for months or years (Morris et al. 1982) . After an initial toxic exposure by ingesting affected fish, these symptoms may be triggered by eating fish with nontoxic levels of the ciguatoxin or consuming alcoholic beverages. One individual (Glasgow et al. 1995) had documented repeated exposures to P. piscicida. Recovery was reported after each exposure. However, with each episode, the intensity and number of symptoms increased and involved more neural and bodily symptoms (see Table 1 ). Unfortunately, it was not until that individual was hospitalized for serious symptoms that he learned the Pfiesteria-associated toxin in his laboratory was the probable case of his episodic illnesses. Fortunately, he was cautioned about this putative neurotoxin before an even more severe medical illness evolved.
Preliminary data in our laboratory, albeit tentative, also raise the possibility that repeated environmental exposures at low levels may produce symptoms in some people. Data from clinical case studies to date suggest that exposure to a low-level fish kill event produces alterations in divided attention and memory only in persons with histories of previous highlevel exposure. In cases with a single, low-level exposure, cognitive functions have been consistently assessed as normal. With this potentiality in mind, further studies need to be conducted to examine the conditions under which persons may be at risk for symptom recurrence. 
Conclusions
Diverse medical, neurologic, and cognitive symptoms have been reported after presumed exposure to a Pfiesteriarelated toxin in the laboratory and environmental setting. Acute medical, neurologic, dermatologic, and neuropsychological symptoms usually occur within hours of exposure cessation, and there appears to be a general dose-response relationship between exposure, severity of neuropsychological disturbance, and recovery time. The actual medical and neurologic effects of exposure appear to subside within a few days to a week and the neuropsychological sequelae appear reversible within 1 to 6 months, depending on the severity of exposure. There is evidence that several hours of intense exposure may produce more severe symptoms than a lower-level exposure of longer duration. The possibility has also been raised that symptoms may reoccur with repeated, low-level exposures in persons with a history of intense exposure. One of the greatest barriers to the current investigation of human health effects of exposure to P. piscicida is the lack of an assay for toxin identification. Thus, while the convergence of data suggests that a Pfiesteria-related toxin causes human illness, it could be argued that another toxin-producing organism (e.g., Gyrodimium spp., Cryptoperidinopsoid organisms), or variations of this organism, are responsible for the estuary-related human illnesses observed in the mid-Atlantic coastal state (Oldach et al. 1999) . The ongoing development of new assays for marine toxin identification is critical to advancing the link between exposure and human illness. Once the specific toxin is characterized, however, it is likely that a wide range of neurologic and neuropsychologic effects will be found to be associated with estuary-induced neurotoxicity. As in reactions to other neurotoxins, human reactions to exposure are mitigated by numerous additional factors, including intensive of exposure; duration of exposure (chronic low level versus intermittent high level); route of exposure (dermal versus inhalation); confounding environmental factors; confounding behavioral factors; baseline cognitive status; developmental, neurologic, psychiatric, or substance abuse history; and genetics. We anticipate that the relationship between exposure, medical symptoms, and human neurologic and neuropsychological sequelae will ultimately be very complex.
